Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016
- PMID: 29894910
- PMCID: PMC6062451
- DOI: 10.1016/j.drugalcdep.2018.04.026
Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016
Abstract
Background: A cascade of care framework has been proposed to identify and address implementation gaps in addiction medicine. Using this framework, we characterized temporal trends in engagement in care for opioid use disorder (OUD) in Vancouver, Canada.
Methods: Using data from two cohorts of people who use drugs, we assessed the yearly proportion of daily opioid users achieving four sequential stages of the OUD cascade of care [linkage to addiction care; linkage to opioid agonist treatment (OAT); retention in OAT; and stability] between 2006 and 2016. We evaluated temporal trends of cascade indicators, adjusting for socio-demographic characteristics, HIV/HCV status, substance use patterns, and social-structural exposures.
Results: We included 1615 daily opioid users. Between 2006 and 2016, we observed improvements in linkage to care (from 73.2% to 78.9%, p = <0.001), linkage to (from 69.2% to 70.6%, p = 0.011) and retention in OAT (from 29.1% to 35.5%, p = <0.001), and stability (from 10.4% to 17.1%, p = <0.001). In adjusted analyses, later calendar year of observation was associated with increased odds of linkage to care (Adjusted Odds Ratio [AOR] = 1.02, 95% Confidence Interval [CI]: 1.01-1.04), retention in OAT (AOR 1.02, 95% CI: 1.01-1.04) and stability (AOR = 1.03, 95% CI: 1.01-1.05), but not with linkage to OAT (AOR 1.00, 95% CI: 0.98-1.01).
Conclusions: Temporal improvements in OUD cascade of care indicators were observed. However, only a third of participants were retained in OAT in 2016. These findings suggest the need for novel approaches to improve engagement in care for OUD to address the escalating opioid-related overdose crisis.
Keywords: Addiction; Buprenorphine/naloxone; Cascade of care; Methadone; Opioid agonist therapy; Opioid use disorder; Performance metrics; Quality indicators.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
The University of British Columbia has received unstructured funding from NG Biomed, Ltd., an applicant to the Canadian federal government for a licence to produce medical cannabis, to support M-JM. JM has received limited unrestricted funding, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. All other authors declare no competing interests.
Figures
Similar articles
-
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.Addiction. 2020 Aug;115(8):1482-1493. doi: 10.1111/add.14947. Epub 2020 Feb 6. Addiction. 2020. PMID: 31899565
-
High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20. Addiction. 2018. PMID: 30238568 Free PMC article.
-
Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6. Drug Alcohol Depend. 2018. PMID: 30340144 Free PMC article.
-
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31891578 Free PMC article.
-
The cascade of care for opioid use disorder among youth in British Columbia, 2018.J Subst Abuse Treat. 2021 Nov;130:108404. doi: 10.1016/j.jsat.2021.108404. Epub 2021 Apr 18. J Subst Abuse Treat. 2021. PMID: 34118696 Review.
Cited by
-
Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.Drug Alcohol Depend. 2019 Feb 1;195:114-120. doi: 10.1016/j.drugalcdep.2018.11.026. Epub 2018 Dec 26. Drug Alcohol Depend. 2019. PMID: 30611979 Free PMC article.
-
Emergency medical services targeting opioid user disorder: An exploration of current out-of-hospital post-overdose interventions.J Am Coll Emerg Physicians Open. 2020 Aug 7;1(6):1230-1239. doi: 10.1002/emp2.12208. eCollection 2020 Dec. J Am Coll Emerg Physicians Open. 2020. PMID: 33392528 Free PMC article.
-
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.Drug Alcohol Depend. 2023 Nov 1;252:110963. doi: 10.1016/j.drugalcdep.2023.110963. Epub 2023 Sep 14. Drug Alcohol Depend. 2023. PMID: 37748421 Free PMC article.
-
What is the ideal time to begin tapering opioid agonist treatment? A protocol for a retrospective population-based comparative effectiveness study in British Columbia, Canada.BMJ Open. 2024 Apr 29;14(4):e083453. doi: 10.1136/bmjopen-2023-083453. BMJ Open. 2024. PMID: 38684262 Free PMC article.
-
Quantifying opioid use disorder Cascade of Care outcomes in an American Indian tribal nation in Minnesota.Drug Alcohol Depend. 2021 May 1;222:108661. doi: 10.1016/j.drugalcdep.2021.108661. Epub 2021 Mar 18. Drug Alcohol Depend. 2021. PMID: 33775445 Free PMC article.
References
-
- Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: Visualizing the gaps. Ann Intern Med. 2014;161:681–689. - PubMed
-
- Ali-Faisal SF, Colella TJ, Medina-Jaudes N, Benz Scott L. The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials. Patient Educ Couns. 2017;100:436–448. - PubMed
-
- BC Coroners Service. Illicit Drug Overdose Deaths in BC (Jan 2008 – Feb 2018) 2018.
-
- Byers T. Assessing the value of patient navigation for completing cancer screening. Cancer Epidemiol Biomarkers Prev. 2012;21:1618–1619. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical